Blood GFAP as an emerging biomarker in brain and spinal cord disorders
2022 · Nature Reviews Neurology · 763 citations
https://doi.org/10.1038/s41582-021-00616-3
A
André Huss
Universität Ulm(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
3.3K
Citations
24
h-index
33
i10-index
André Huss is an academic researcher from Universität Ulm. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Amyotrophic Lateral Sclerosis Research & Peripheral Neuropathies and Disorders. The author has an h-index of 24, co-authored 52 publications.
ORCID: 0000-0002-2761-7591Papers by this author
worksSerum GFAP as a biomarker for disease severity in multiple sclerosis
2018 · Scientific Reports · 269 citations
https://doi.org/10.1038/s41598-018-33158-8
S1 guidelines “lumbar puncture and cerebrospinal fluid analysis” (abridged and translated version)
2020 · Neurological Research and Practice · 73 citations
https://doi.org/10.1186/s42466-020-0051-z
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
2023 · EBioMedicine · 44 citations
https://doi.org/10.1016/j.ebiom.2023.104521
Optical coherence tomography-based assessment of retinal vascular pathology in cerebral small vessel disease
2020 · Neurological Research and Practice · 15 citations
https://doi.org/10.1186/s42466-020-00062-4
Primary lateral sclerosis: application and validation of the 2020 consensus diagnostic criteria in an expert opinion-based PLS cohort
2024 · Journal of Neurology Neurosurgery & Psychiatry · 6 citations
https://doi.org/10.1136/jnnp-2023-333023
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat